| Biological roles of fibroblast growth factor-2 A Bikfalvi, S Klein, G Pintucci, DB Rifkin Endocrine reviews 18 (1), 26-45, 1997 | 1351 | 1997 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 546 | 2018 |
| Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells H Bompais, J Chagraoui, X Canron, M Crisan, XH Liu, A Anjo, ... Blood 103 (7), 2577-2584, 2004 | 378 | 2004 |
| The role of fibroblast growth factors in vascular development S Javerzat, P Auguste, A Bikfalvi Trends in molecular medicine 8 (10), 483-489, 2002 | 360 | 2002 |
| Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma G Auf, A Jabouille, S Guérit, R Pineau, M Delugin, M Bouchecareilh, ... Proceedings of the National Academy of Sciences 107 (35), 15553-15558, 2010 | 351 | 2010 |
| IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth In vivo B Drogat, P Auguste, DT Nguyen, M Bouchecareilh, R Pineau, ... Cancer research 67 (14), 6700-6707, 2007 | 297 | 2007 |
| Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight … A Bikfalvi, S Klein, G Pintucci, N Quarto, P Mignatti, DB Rifkin The Journal of cell biology 129 (1), 233-243, 1995 | 251 | 1995 |
| Low-dose Chemotherapy Combined with an Antiangiogenic Drug Reduces Human Glioma Growth in Vivo L Bello, G Carrabba, C Giussani, V Lucini, F Cerutti, F Scaglione, ... Cancer research 61 (20), 7501-7506, 2001 | 239 | 2001 |
| Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization C Perollet, ZC Han, C Savona, JP Caen, A Bikfalvi Blood, The Journal of the American Society of Hematology 91 (9), 3289-3299, 1998 | 237 | 1998 |
| Accessing key steps of human tumor progression in vivo by using an avian embryo model M Hagedorn, S Javerzat, D Gilges, A Meyre, B de Lafarge, A Eichmann, ... Proceedings of the National Academy of Sciences 102 (5), 1643-1648, 2005 | 230 | 2005 |
| Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis JW Shin, M Min, F Larrieu-Lahargue, X Canron, R Kunstfeld, L Nguyen, ... Molecular biology of the cell 17 (2), 576-584, 2006 | 222 | 2006 |
| Recent advances in angiogenesis, anti-angiogenesis and vascular targeting A Bikfalvi, R Bicknell Trends in pharmacological sciences 23 (12), 576-582, 2002 | 216 | 2002 |
| Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors S North, M Moenner, A Bikfalvi Cancer letters 218 (1), 1-14, 2005 | 204 | 2005 |
| The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation P Auguste, L Fallavollita, N Wang, J Burnier, A Bikfalvi, P Brodt The American journal of pathology 170 (5), 1781-1792, 2007 | 203 | 2007 |
| Molecular mechanisms of tumor vascularization P Auguste, S Lemiere, F Larrieu-Lahargue, A Bikfalvi Critical reviews in oncology/hematology 54 (1), 53-61, 2005 | 202 | 2005 |
| Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and-independent mechanisms P Auguste, DB Gürsel, S Lemiere, D Reimers, P Cuevas, F Carceller, ... Cancer Research 61 (4), 1717-1726, 2001 | 195 | 2001 |
| Target molecules for anti-angiogenic therapy: from basic research to clinical trials M Hagedorn, A Bikfalvi Critical reviews in oncology/hematology 34 (2), 89-110, 2000 | 188 | 2000 |
| HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism D Mottet, S Pirotte, V Lamour, M Hagedorn, S Javerzat, A Bikfalvi, ... Oncogene 28 (2), 243-256, 2009 | 185 | 2009 |
| CXCR3, a double-edged sword in tumor progression and angiogenesis C Billottet, C Quemener, A Bikfalvi Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (2), 287-295, 2013 | 179 | 2013 |
| Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2 L Bello, V Lucini, G Carrabba, C Giussani, M Machluf, M Pluderi, D Nikas, ... Cancer research 61 (24), 8730-8736, 2001 | 175 | 2001 |
